inspra 25mg tablets
sigma pharmaceuticals plc - eplerenone - oral tablet - 25mg
inspra 25mg tablets
de pharmaceuticals - eplerenone - oral tablet - 25mg
inspra 25 mg film-coated tablets
upjohn eesv - eplerenone - film-coated tablet - 25 milligram(s) - aldosterone antagonists; eplerenone
inspra 50 mg film-coated tablets
upjohn eesv - eplerenone - film-coated tablet - 50 milligram(s) - aldosterone antagonists; eplerenone
nasoxinspray- sodium chloride spray spray
friana llc - sodium chloride (unii: 451w47iq8x) (sodium cation - unii:lyr4m0nh37) -
inspra 25 mg
pfizer pharmaceuticals israel ltd - eplerenone 25 mg - film coated tablets - eplerenone - inspra is indicated, in addition to standard therapy including beta-blockers, to reduce the risk of cardiovascular mortality and morbidity in stable patients with left ventricular dysfunction (lvef < 40 % ) and clinical evidence of heart failure after recent myocardial infarction.
inspra 50 mg
pfizer pharmaceuticals israel ltd - eplerenone 50 mg - film coated tablets - eplerenone - inspra is indicated, in addition to standard therapy including beta-blockers, to reduce the risk of cardiovascular mortality and morbidity in stable patients with left ventricular dysfunction (lvef < 40 % ) and clinical evidence of heart failure after recent myocardial infarction.
inspra 50 mg 30 comprimits coberta pel·lícular
inspra 25 mg 30 comprimits coberta pel·lícular
inspra 25 milligram film coated tablet
clear pharmacy - eplerenone - film coated tablet - 25 milligram - aldosterone antagonists